QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
AMC   33.94 (-7.87%)
PFE   53.73 (+2.54%)
BA   197.85 (-0.33%)
OTCMKTS:IPSEY

Ipsen Stock Forecast, Price & News

$24.06
-0.71 (-2.87%)
(As of 11/30/2021 01:50 PM ET)
Add
Compare
Today's Range
$24.06
$24.06
50-Day Range
$23.38
$26.60
52-Week Range
$19.35
$28.10
Volume
697 shs
Average Volume
2,762 shs
Market Capitalization
$8.07 billion
P/E Ratio
N/A
Dividend Yield
0.77%
Beta
1.13
30 days | 90 days | 365 days | Advanced Chart
Receive IPSEY News and Ratings via Email

Sign-up to receive the latest news and ratings for Ipsen and its competitors with MarketBeat's FREE daily newsletter.


Ipsen logo

About Ipsen

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults an

Headlines

Ipsen S.A. (OTCMKTS:IPSEY) Short Interest Down 94.4% in November
November 27, 2021 |  americanbankingnews.com
Ipsen (OTCMKTS:IPSEY) Research Coverage Started at Berenberg Bank
November 24, 2021 |  americanbankingnews.com
Ipsen (OTCMKTS:IPSEY) Downgraded by Morgan Stanley
November 5, 2021 |  americanbankingnews.com
Ipsen Pledges Ambitious Action on Climate Change
October 27, 2021 |  finance.yahoo.com
Ipsen Adds Another Program Into Its Pre-Clinical...
October 18, 2021 |  benzinga.com
Ipsen S.A. (IPSEY) Investor Presentation - Slideshow
September 24, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IPSEY
CIK
N/A
Employees
5,700
Year Founded
N/A

Sales & Book Value

Annual Sales
$3.07 billion
Cash Flow
$2.74 per share
Book Value
$7.23 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$8.07 billion
Optionable
Not Optionable

Company Calendar

Today
11/30/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Ipsen (OTCMKTS:IPSEY) Frequently Asked Questions

Is Ipsen a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ipsen in the last year. There are currently 2 sell ratings, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Ipsen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IPSEY, but not buy additional shares or sell existing shares.
View analyst ratings for Ipsen
or view top-rated stocks.

How has Ipsen's stock been impacted by Coronavirus (COVID-19)?

Ipsen's stock was trading at $14.4150 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IPSEY shares have increased by 66.9% and is now trading at $24.06.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Ipsen?

Ipsen saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 100 shares, a decrease of 94.4% from the October 31st total of 1,800 shares. Based on an average daily trading volume, of 5,300 shares, the days-to-cover ratio is presently 0.0 days.
View Ipsen's Short Interest
.

How often does Ipsen pay dividends? What is the dividend yield for Ipsen?

Ipsen announced a dividend on Tuesday, May 25th. Stockholders of record on Monday, May 31st will be paid a dividend of $0.5877 per share on Wednesday, June 9th. This represents a yield of 2.21%. The ex-dividend date is Friday, May 28th.
View Ipsen's dividend history
.

Is Ipsen a good dividend stock?

Ipsen pays an annual dividend of $0.19 per share and currently has a dividend yield of 0.77%.
View Ipsen's dividend history.

Who are Ipsen's key executives?

Ipsen's management team includes the following people:
  • David G. Loew, Chief Executive Officer & Director
  • Aymeric Le Chatelier, Chief Financial Officer & Executive Vice President
  • Aidan Murphy, Executive Vice President-Technical Operations
  • Howard Mayer, Executive Vice President-Research & Development
  • Steven Hildemann, Chief Medical Officer & Executive Vice President

What is Ipsen's stock symbol?

Ipsen trades on the OTCMKTS under the ticker symbol "IPSEY."

How do I buy shares of Ipsen?

Shares of IPSEY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ipsen's stock price today?

One share of IPSEY stock can currently be purchased for approximately $24.06.

How much money does Ipsen make?

Ipsen has a market capitalization of $8.07 billion and generates $3.07 billion in revenue each year.

How many employees does Ipsen have?

Ipsen employs 5,700 workers across the globe.

What is Ipsen's official website?

The official website for Ipsen is www.ipsen.com.

Where are Ipsen's headquarters?

How can I contact Ipsen?

Ipsen's mailing address is 65 quai Georges Gorse, Boulogne-Billancourt cedex I0, 92650. The company can be reached via phone at (315) 833-5000, via email at [email protected], or via fax at 33-01-58-33-50-01.


This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.